[Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
The majority of publications in the recent years emphasizes the importance of mucolytic preparations in the upper respiratory tract diseases. There have been very few report about the important role which mucolytic drugs may play in the diseases of the upper respiratory tract. This paper undertakes the task of attempting to evaluate the usefulness of Mucosolvan preparation in laryngological diseases. The main condition of the successful treatment of otolaryngological diseases is maintaining the efficient mechanism of the clearing of upper respiratory tract. This is achieved by means of the mucocilia apparatus, namely cilia and mucosa protecting the epithelium from harmful factors. Tests were carried out on 60 patients with paranasal sinuses and ear diseases. The first group comprised 45 patients who were qualified on the basis of inflammatory changes in paranasal sinuses. The second group comprised 12 children and 3 adults with otitis media with effusion. Mucosolvan which was used in the supplementary treatment fulfilled our expectations. The use of the mucolytic drug accelerated the healing process, proper regeneration of the epithelium and the reduction of the period of drug administration.
Szmeja
Z
Z
Kliniki Otolaryngologii Katedry Chorób Ucha, Nosa, Gardła i Krtani AM im. K. Marcinkowskiego w Poznaniu.
Golusiński
W
W
Mielcarek-Kuchta
D
D
Laczkowska-Przybylska
J
J
D000293:Adolescent; D000328:Adult; D000551:Ambroxol / Q000627:therapeutic use*; D002648:Child; D005100:Expectorants / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010034:Otitis Media with Effusion / Q000188:drug therapy; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy
D005100:Expectorants; D000551:Ambroxol